News search
 About the CNIC 13 Apr 2026 TARGET-DC, CNIC initiative led by Dr. David Sancho aims to identify novel immune checkpoints in dendritic cells to advance T-cell activation. |
 About the CNIC 31 Mar 2026 The initiative will combine innovative medical and digital technologies to improve the early detection of cardiac risk and complications in cancer patients and survivors |
 About the CNIC 5 Mar 2026 Justin Perry, Associate Member in the Immunology Program of the Sloan Kettering Institute at Memorial Sloan Kettering Cancer Center and an Assistant Professor in the Immunology and Microbial Pathogenesis Program at Weill Cornell Medical Center |
 Research 26 Feb 2026 The study shows that a simple, non-pharmacological technique known as remote ischemic conditioning (RIC) can protect the heart during treatment with anthracyclines |
 Research 14 Jan 2026 A CNIC research team has identified for the first time the biological mechanism underlying this susceptibility: high blood pressure creates a hidden metabolic vulnerability in the heart that becomes destabilized when anthracyclines are administered. |
 About the CNIC 20 Nov 2025 In this latest round, the la Caixa Foundation Health Research Call has selected 34 new cutting-edge biomedical research projects |
 About the CNIC 23 Oct 2025 |
 Research 12 Aug 2025 El 18FDG-PET is a type of positron emission tomography that measures how much energy the body’s cells consume. |
 |
 Research 14 Apr 2025 A study led by the Centro Nacional de Investigaciones Cardiovasculares Carlos III (CNIC), in collaboration with the Instituto de Investigación Biomédica de Barcelona (IRB Barcelona), has identified the most effective subtype of dendritic cell for generating immune memory in response to cancer |
- 1 of 4
- next ›
